Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyFastRx vs Rivas Medical Weight Loss

MyFastRx
Graded #172

Higher grade

vs+11.800000000000004
Rivas Medical Weight Loss
Graded #438

Lower grade

The verdict

MyFastRx takes it — 67.4/100 to 55.6/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +30
75
45
Dose & formulationMyFastRx +32
72
40
Clinical oversightRivas Medical Weight Loss +15
66
81
Labs & monitoringRivas Medical Weight Loss +1
52
53
FulfillmentMyFastRx +18
83
65
Contract termsRivas Medical Weight Loss +14
41
55
MyFastRx · left barRivas Medical Weight Loss · right bar

The numbers

MetricMyFastRxRivas Medical Weight Loss
WeighScore67.4/10055.6/100
GradeCC
Scorecard rank#172#438
Semaglutide$169/moNot disclosed
Tirzepatide$249/moNot disclosed
CoverageAll 50 states3 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
MyFastRx

Graded #172 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Strengths

  • Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
  • Flat price for any dose; weekly provider visits included in every payment
  • Offers both compounded semaglutide and tirzepatide

Where it loses points

  • Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
  • Only available in Maryland, Virginia, and Florida
  • Weekly-visit concierge model requires more frequent engagement than mail-order

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard